Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: AMA/Sunbeam alliance

This article was originally published in The Gray Sheet

Executive Summary

AMA/Sunbeam alliance: Sunbeam files suit Sept. 8 in the Federal District Court in Chicago in an effort to hold the American Medical Association to the terms of a five-year marketing/educational agreement, which included the use of the AMA symbol on over-the-counter Sunbeam health care products in exchange for inclusion of AMA educational materials with the products ("The Gray Sheet" Aug. 25, In Brief). AMA decided to put the agreement on hold after concerns were raised that the use of the association's symbol may be construed as product endorsement. Sunbeam says that AMA has notified them that they do not intend to honor the contract. "The AMA cannot just change its mind and expect to walk away from [the] agreement because of adverse publicity directed at the AMA," Al Dunlap, chairman of Sunbeam, said in a Sept. 8 release...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008761

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel